NEW YORK (GenomeWeb) – Namocell announced today that it has signed an agreement with Tomy Digital Biology to distribute Namocell's Namo Single Cell Dispenser in Japan.

Financial details of the agreement were not disclosed.

Namocell's microfluidic-based cell platforms dispense single cells into a 96-well plate in less than a minute, the company said. The firm added that its cell cartridges simplify sterile sorting and eliminate the potential for system clogging.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.